371 – 380 of 1963
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men
(
- Contribution to journal › Article
-
Mark
Immune gene expression and response to chemotherapy in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
-
Mark
Determinants for local tumour control probability after radiotherapy of anal cancer
(
- Contribution to journal › Article
-
Mark
Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX)
(
- Contribution to journal › Article
-
Mark
CM-Score : A validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe
(
- Contribution to journal › Article
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
(
- Contribution to journal › Article
-
Mark
Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment
(
- Contribution to journal › Article
-
Mark
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
(
- Contribution to journal › Article
-
Mark
Genetic modifiers of radon-induced lung cancer risk : a genome-wide interaction study in former uranium miners
(
- Contribution to journal › Article